Order Article Reprints

Noel J, Jouinot A, Alexandre J, Ulmann G, Bretagne M, Castel-Ajgal Z, De Percin S, Vaquin-Villeminey C, Revel M-P, Peyromaure M, et al. Association of Energy Expenditure and Efficacy in Metastatic Renal Cell Carcinoma Patients Treated with Nivolumab. Cancers. 2022; 14(13):3214. https://doi.org/10.3390/cancers14133214

Noel, Johanna, Anne Jouinot, Jérôme Alexandre, Guillaume Ulmann, Marie Bretagne, Zahra Castel-Ajgal, Sixtine De Percin, Clémentine Vaquin-Villeminey, Marie-Pierre Revel, Michael Peyromaure, and et al. 2022. "Association of Energy Expenditure and Efficacy in Metastatic Renal Cell Carcinoma Patients Treated with Nivolumab" Cancers 14, no. 13: 3214. https://doi.org/10.3390/cancers14133214

Noel, J., Jouinot, A., Alexandre, J., Ulmann, G., Bretagne, M., Castel-Ajgal, Z., De Percin, S., Vaquin-Villeminey, C., Revel, M.-P., Peyromaure, M., Boudou-Rouquette, P., Arrondeau, J., Gataa, I., Durand, J.-P., Goldwasser, F., & Huillard, O. (2022). Association of Energy Expenditure and Efficacy in Metastatic Renal Cell Carcinoma Patients Treated with Nivolumab. Cancers, 14(13), 3214. https://doi.org/10.3390/cancers14133214